Listed equity · As of 2 Jul 2026
Strides Pharma Science
स्ट्राइड्स फार्मा· સ્ટ્રાઇડ્સ આર્કોલેબ
NSE: STARBSE: 532531
₹1093.65
+2.42%
Phase indicator
mid rally-11.2% from 52w high
Above 50- and 200-day MAs with +15.7% over 3 months — established uptrend.
1M
+4.3%
3M
+15.7%
1Y
+29.1%
Delivery conviction
neutralscore +15
Delivery vs 20-day avg1.20x
Quiet accumulation active for 1 consecutive day. See full screener
Lifetime story
Strides Pharma Science is up 1703.2% from its lifetime low of ₹60.65 on 5 Mar 2009. ₹10,000 invested then would be worth ₹1,80,322 today (18.2% CAGR over 17.3 years). Lifetime high of ₹1675.25 was set on 17 Oct 2024 (currently -34.7% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
14% premium to industry(Industry P/E 49.3)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 56.34 | 18.60 |
| P/B | 3.16 | 3.33 |
| Price / Cash flowsubs material | 37.64 | 13.64 |
| Dividend yield | 0.45% | 0.45% |
| Book value / share | 356.24 ₹ | 337.15 ₹ |
| EPS (TTM)subs material | 19.92 ₹ | 60.34 ₹ |
Market cap
₹10.3K Cr
52W high
₹1231.45
12 May 2026
52W low
₹769.60
29 Jan 2026
Returns ladder
1W
+3.6%
1M
+4.3%
3M
+15.7%
6M
+24.6%
YTD
+24.4%
1Y
+29.1%
3Y
+160.9%
5Y
+43.6%
10Y
-4.6%